| Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19 S Neumann-Böhme, NE Varghese, I Sabat, PP Barros, W Brouwer, ... The European Journal of Health Economics 21, 977-982, 2020 | 920 | 2020 |
| Economic valuation of informal care B Van den Berg, WBF Brouwer, MA Koopmanschap The European Journal of Health Economics, formerly: HEPAC 5 (1), 36-45, 2004 | 507 | 2004 |
| Welfarism vs. extra-welfarism WBF Brouwer, AJ Culyer, NJA van Exel, FFH Rutten Journal of health economics 27 (2), 325-338, 2008 | 443 | 2008 |
| The CarerQol instrument: a new instrument to measure care-related quality of life of informal caregivers for use in economic evaluations WBF Brouwer, NJA Van Exel, B Van Gorp, WK Redekop Quality of Life Research 15, 1005-1021, 2006 | 353 | 2006 |
| Lifetime medical costs of obesity: prevention no cure for increasing health expenditure PHM van Baal, JJ Polder, GA de Wit, RT Hoogenveen, TL Feenstra, ... PLoS medicine 5 (2), e29, 2008 | 341 | 2008 |
| The iMTA productivity cost questionnaire: a standardized instrument for measuring and valuing health-related productivity losses C Bouwmans, M Krol, H Severens, M Koopmanschap, W Brouwer, ... Value in health 18 (6), 753-758, 2015 | 321 | 2015 |
| Productivity losses without absence: measurement validation and empirical evidence WBF Brouwer, MA Koopmanschap, FFH Rutten Health policy 48 (1), 13-27, 1999 | 288 | 1999 |
| Costing in economic evaluations W Brouwer, FFH Rutten, M Koopmanschap Economic evaluation in health care; merging theory with practice, 68-93, 2001 | 275 | 2001 |
| An overview of methods and applications to value informal care in economic evaluations of healthcare MA Koopmanschap, NJA van Exel, B van den Berg, WBF Brouwer Pharmacoeconomics 26, 269-280, 2008 | 264 | 2008 |
| Need for differential discounting of costs and health effects in cost effectiveness analyses WBF Brouwer, LW Niessen, MJ Postma, FFH Rutten Bmj 331 (7514), 446-448, 2005 | 263 | 2005 |
| Productivity costs measurement through quality of life? A response to the recommendation of the Washington Panel WBF Brouwer, MA Koopmanschap, FFH Rutten Health Economics 6 (3), 253-259, 1997 | 251 | 1997 |
| Process utility from providing informal care: the benefit of caring WBF Brouwer, NJA van Exel, B van den Berg, GAM van den Bos, ... Health policy 74 (1), 85-99, 2005 | 241 | 2005 |
| Discounting in economic evaluations AE Attema, WBF Brouwer, K Claxton Pharmacoeconomics 36, 745-758, 2018 | 240 | 2018 |
| Discounting and decision making in the economic evaluation of health‐care technologies K Claxton, M Paulden, H Gravelle, W Brouwer, AJ Culyer Health economics 20 (1), 2-15, 2011 | 234 | 2011 |
| Economic valuation of informal care: lessons from the application of the opportunity costs and proxy good methods B Van den Berg, W Brouwer, J van Exel, M Koopmanschap, ... Social science & medicine 62 (4), 835-845, 2006 | 231 | 2006 |
| Caring for and caring about: disentangling the caregiver effect and the family effect A Bobinac, NJA Van Exel, FFH Rutten, WBF Brouwer Journal of health economics 29 (4), 549-556, 2010 | 230 | 2010 |
| Burden of informal caregiving for stroke patients NJA Van Exel, MA Koopmanschap, B van den Berg, WBF Brouwer, ... Cerebrovascular diseases 19 (1), 11-17, 2005 | 224 | 2005 |
| Quality of life instruments for economic evaluations in health and social care for older people: a systematic review P Makai, WBF Brouwer, MA Koopmanschap, EA Stolk, AP Nieboer Social science & medicine 102, 83-93, 2014 | 223 | 2014 |
| Burden of caregiving: evidence of objective burden, subjective burden, and quality of life impacts on informal caregivers of patients with rheumatoid arthritis WBF Brouwer, NJA van Exel, B Van De Berg, HJ Dinant, ... Arthritis Care & Research 51 (4), 570-577, 2004 | 222 | 2004 |
| Productivity costs in economic evaluations: past, present, future M Krol, W Brouwer, F Rutten Pharmacoeconomics 31, 537-549, 2013 | 214 | 2013 |
Job van ExelErasmus University Rotterdam在 eshpm.eur.nl 的电子邮件经过验证
